Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
0.6321 USD | -4.23% | -13.78% | -87.11% |
Mar. 15 | Maxim Group Adjusts Quoin Pharmaceuticals Price Target to $4 From $15, Maintains Buy Rating | MT |
Mar. 14 | Quoin Pharmaceuticals Seeks M&A Opportunities | CI |
This article is reserved for members
Already a member?
Log InNot a member ?
Free registrationEPS Revisions
1st Jan change | Capi. | |
---|---|---|
-87.11% | 2.43M | |
+4.09% | 43.43B | |
+47.81% | 41.69B | |
+9.45% | 41.31B | |
-10.92% | 27.14B | |
+9.32% | 25.28B | |
-24.87% | 18.47B | |
+29.70% | 12.59B | |
+1.28% | 12.33B | |
+7.78% | 11.03B |
- Stock Market
- Equities
- QNRX Stock
- News Quoin Pharmaceuticals, Ltd.
- Quoin Pharmaceuticals Signs Exclusive Licensing, Distribution Deal With AFT Pharmaceuticals For QRX003